Patents by Inventor Adele CUTIGNANO

Adele CUTIGNANO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use and preparation of glycolipids as adjuvants in vaccines
    Patent number: 10722574
    Abstract: The present invention relates to beta-glycolipid derivatives, their preparation and use as adjuvants in vaccines, as being suitable for being co-administered with antigens for vaccine prophylaxis and therapy. In certain embodiments, the beta-glycolipid derivatives of the invention also in their salified or complex form, are suitable for being co-administered with antigens for both therapeutic and prophylactic purposes or for vaccine prophylaxis and therapy.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: July 28, 2020
    Assignee: CONSIGLIO NAZIONALE DELLE RICERCHE
    Inventors: Angelo Fontana, Emiliano Manzo, Adele Cutignano, Raffaele De Palma
  • USE AND PREPARATION OF GLYCOLIPIDS AS ADJUVANTS IN VACCINES
    Publication number: 20180344843
    Abstract: The present invention relates to beta-glycolipid derivatives, their preparation and use as adjuvants in vaccines, as being suitable for being co-administered with antigens for vaccine prophylaxis and therapy. In certain embodiments, the beta-glycolipid derivatives of the invention also in their salified or complex form, are suitable for being co-administered with antigens for both therapeutic and prophylactic purposes or for vaccine prophylaxis and therapy.
    Type: Application
    Filed: June 13, 2018
    Publication date: December 6, 2018
    Inventors: Angelo FONTANA, Emiliano MANZO, Adele CUTIGNANO, Raffaele DE PALMA
  • BETA-GLYCOLIPIDS FOR USE AS ADJUVANTS
    Publication number: 20160151483
    Abstract: The present invention relates to beta-glycolipid derivatives, their preparation and use as adjuvants in vaccines, as being suitable for being co-administered with antigens for vaccine prophylaxis and therapy. In certain embodiments, the beta-glycol-lipid derivatives of the invention also in their salified or complex form, are suitable for being co-administered with antigens for both therapeutic and prophylactic purposes or for vaccine prophylaxis and therapy.
    Type: Application
    Filed: June 10, 2014
    Publication date: June 2, 2016
    Inventors: Angelo FONTANA, Emiliano MANZO, Adele CUTIGNANO, Raffaele DE PALMA